Journal honors Christopher Lieu, MD, as recipient of the 2010 JCO Young Investigator Award.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001363:Awards and Prizes; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D005346:Fibroblast Growth Factors / Q000378:metabolism; D049674:History, 21st Century; D008495:Medical Oncology / Q000266:history*; D014481:United States
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005346:Fibroblast Growth Factors